CHEMIOPROFYLAXIS IN GENERAL MEDICINE
Abstract
No AbstractReferences
Frank Ρ, Stollerman G, Miller L: Protection of a military population from rheumatic fever. JAMA, 1965;193:755
Committee of Rheumatic Fever, Endocarditis, and Kawasaki Disease, American Heart Association. Prevention of rheumatic fever. Circulation 1988;70:1118A
Massel Β, Christopher C, Walker Α and Kurland G: Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. Ν Engl J Med 318:280, 1988
Wood HF, Feinstein AR, Taranta Α, et al.: Rheumatic fever in children and adolescents. III. Comparative effectiνeness of three prophylaxis regiments in preventing streptococcal infections and rheumatic recurrences. Αnn Intern Med, 1964;60(Suppl. 5):31
Committee οn the prevention of Rheumatic Fever and Bacterial Endocarditis of the American Heart Association: Preνention of rheumatic fever. Circulation 1988;78:1082
Kaplan EL, Bisno Α, Derrick W. et al: AHA Committee Report: prevention of rheumatic fever. Circulation 1977;55:1
Bisno Α: Nonsuppurative sequellae of group Α streptococcal infection. Ιn: Kass Ε, ed. Current Therapy ίn Infectious Disease - 3. Toronto, B.C. Decker, 1990:308-11
Centers for disease Control: Sexually transmitted diseases treatment guidelines. MMWR 1989;38(suppl 8): 1
Holmes Κ, Morse S: Gonococcal infections. Ιn: Wilson J, Braunwald Ε, Isselbacher,Petersdorf R, Martin J, Fauci Α, Root R, eds. Harrison's Principles of Internal Medicine, New York, McGraw-Hill, 1991:593-99
Siegel MS, Thornsberry C, Biddle JW, et al: Penicillinace-producίng Neisseria gonorrhoeae: results of surveillance in the United States. J Infect Dis 1978;137:170
Lukehart S, Holmes Κ: Syphilis. In: Wilson J, Braunwald Ε, Isselbacher, Petersdorf R, Martin J, Fauci Α, Root R, eds. Harrison's Ρrinciples of Internal Medicine, New Υork, McGraw-Hill, 1991:651-61
Stamm WE, McKevitt Μ, Counts GW, et al: Is antimicrobial prophylaxis of urinary tract infections cost effective? Ann Intern Med 1981;94:251
Nicole LE, Ronald AR: Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987;1:793
Nicole LΕ, Harding GKM, Thompson Μ, et al: Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in Women. Antimicrob Agents Chemother 1989;33:1032
Harding GKM, Ronald AR, Nicolle LE, et al: long-term antimicrobial prophylaxis for recurrent urinary tract infection in women. Rev Infect Dis 1982;4:438
Stapleton Α, Latham RH, Johnson C, et al: Postcoίtal antimicrobial prophylaxis for recurrent urinary tract infection: a randomized, double-blind, placebo-controlled trial. JAMA 1990;264:703
Andriole V, Patterson F: Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 1991;75:359
Greenwood Β: Selective primary health care: strategies for control of disease in developing World ΧΙΙΙ. Acute bacterial meningitis. Rev Inf Dis 1984;6:374
Jacobson JA, Fraser DW: Α simplified approach to meningococcal disease prophylaxis. JAMA 1976;236:1053
Blakebrouh Ι, Giles Η: The effect of rifampicίn on meningococcal carriage in family contacts in Northern Nigeria. Journal of Infection 1980;2:137
Schwarz Β, Al-Tobaiqi Α, Al-Ruwais Α, et al: Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group Α Neisseria meningitidis. Lancet 1988;1:1239
Gaunt Ρ, Lambert Β: Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother 1988;21:489
American Academy of Pediatrics Committee on Infectious Diseases: Revision of recommendation for use of rifampin prophylaxis of contacts of patients with Haemophilus influenzae infection. Pediatrics 1984;74:301
Band JD, Fraser DW, Ajello G, et al: Prevention of Haernophilus influenzae type b disease. JAMA 1984;251:2381
Cartwright KAV, Begg NT, Hull D: Chemoprophylaxis for Haemophilus influenzae type b. BMJ 1991;302:546
Dajani AS, Bisno AL, Chung ΚJ, et al: Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1990;264:2912
Keys TF: Infective endocarditis: a continuing challenge. Update οn causes, presentation, treatment and prophylaxis. J Crit Illness 1987;2:18
Antibiotic prophylaxis of infective endocarditis: recommendations from the Endocarditis working Party of the British Society for Antimicrobial Chemotherapy. Lancet 1990;335:88
Seaton Α, Seaton D, Leith Α: Crofton & Douglas's Respiratory Diseases. Oxford, Blackwell Scientific Publications, fourth Edition, 1989
Medical Research Council: Value of chemotherapy and chemoprophylaxis in early chronic bronchitis. Br Med J 1966;1:1317
Anthonisen NR, Manfreda J, Warren CPW, et al: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:197
American Thoracic Society: Guidelines for the investigation and management of tuberculosis contacts. Am Rev Respir Dis 1976; 114:459
Farer LS: Chcmoprophylaxis against tuberculosis. Clin Chest Med 1980;1:2030
Moulding D: Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors. Arch Intern Med 10001;151:2101
International Union against Tuberculosis Committee οn Prophylaxis: Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull WHO 1982;60:55
Comstock GW: New data on preventive treatment with isoniazid. Αnn Intern Med 1983;98:663
Taylor WC, Aronson MD, Delbanco TL: Should young adults with a positive tuberculin test take isoniazid? Ann lntern Med 1981; 94:808
Kopanof DE, Snider DE Jr, Caras GJ: Isoniazid related hepatitis: a US Public Health Service Cooperatiνe surveillance Study. Am Rev Respir Dis 1978;117:991
Stead WW, Το Τ, Harrison RW, et al: Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med 1987;107:843
Verhoef, Rozenberg-Arska Μ, Dekker Α: Prevention of infection tn the neutropenic patient. Rev Infect Dis 1989; 11 (Suppl 7):51545
Klastersky J: Chemprophylaxis of gramnegative infections in neutropenic patients. Eur Urol 1990; 17 (Suppl 1):40
Winston DJ, Ho WG, Bruckner DA, et al: Ofloxacin versus vamcomycin/polymixin for prevention of infections in granulocytopenic patients. Am J Med 1990;88:36
Pizzo Ρ: The Compromised Host. Ιn: Wyngaarden J, Smith L, eds. Cecil Textbook of Medicine. Philadelphia, W.B. Saunders Company, 19th edition 1992:1573
Kovacs JA, Masur Η: Prophylaxis of Pneumocystis carinii pneumonia: an update. J Infect Dis 1989;160:882
Fishl ΜΑ, Dickinson GM, La Voie L: Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumonocystis carinii pneumonia in AIDS. JAMA 1988;259:1185
Dupont HL, Galindo Ε, Evans DG, et al: Prevention of traveler's diarrhea with trimethoprim- sulphamethoxazole and trimethoprim alone. Gastroenterology 1983;84:75
, National institutes of Health Consensus Development Conference: Traveler's diarrhea. Rev Infect Dis 1986;8(suppl):2
Centers for Disease Control: Recommendation for the prevention of malaria among travellers. MMWR 1990;39(RR-3):1
Wernsdorfer WH: Chemoprophylaxis of malaria: underlying principles and their realization. Med Trop 1990;50:119
Revised dosing regimen for malaria prophylaxis with mefloquine. MMWR 1990;39:630
